Literature DB >> 7504487

Study of interaction of carprofen and its enantiomers with human serum albumin--I. Mechanism of binding studied by dialysis and spectroscopic methods.

M H Rahman1, T Maruyama, T Okada, K Yamasaki, M Otagiri.   

Abstract

The binding of carprofen, a non-steroidal anti-inflammatory drug of the aryl propionic acid class [2-(6-chlorocarbazole)propionic acid], and its enantiomers to human serum albumin (HSA) has been studied by dialysis and spectroscopic methods. Binding parameters obtained by different methods were in close agreement. The binding of carprofen to HSA by both fluorescence and equilibrium dialysis (ED) methods is characterized by two sets of association constants [K1 = 5.1 x 10(6) M-1 (fluorescence) and 3.7 x 10(6) M-1 (ED), K2 = 3.7 x 10(5) M-1 (fluorescence) and 1.3 x 10(5) M-1 (ED)]. The S(+)-enantiomer of carprofen showed slightly higher affinity for HSA than its corresponding antipode by both methods. Different analyses of the binding to HSA suggested the presence of one high affinity site and five to seven low affinity sites for carprofen and its enantiomers on HSA. Fluorescence displacement data implied that carprofen primarily binds to site II, the benzodiazepine site, while the low affinity site of carprofen is site I, the warfarin site. Circular dichroism data suggested different mechanisms for the high affinity and the low affinity binding of carprofen to HSA. The data are consistent with the major part of the binding energy at site II being electrostatic and hydrophobic interactions, whereas for the low affinity binding, hydrophobic interactions. Binding was exothermic, entropy driven and spontaneous, as indicated by the thermodynamic analyses. From binding data with chemically modified HSA derivatives, it is likely that tyrosine, lysine and histidine residues are especially involved in carprofen binding to HSA, and it is most likely that the high affinity binding of carprofen is located in the N-terminal part of domain III or that section of protein plus the C-terminal part of domain II of the HSA molecule. When the binding of carprofen to HSA was compared to the binding of carprofen methyl ester to HSA (K = 0.1 x 10(6) M-1), the carboxyl group of carprofen was found to play an important role especially in the high affinity binding of carprofen to HSA. The high affinity of carprofen to HSA was independent of the conformational changes on HSA caused by N-B transition.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504487     DOI: 10.1016/0006-2952(93)90576-i

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

1.  Molecular interaction of PCB180 to human serum albumin: insights from spectroscopic and molecular modelling studies.

Authors:  Senbiao Fang; Huanhuan Li; Tao Liu; Hongxia Xuan; Xin Li; Chunyan Zhao
Journal:  J Mol Model       Date:  2014-03-16       Impact factor: 1.810

2.  The binding characteristics of the interaction between 3-(2-cyanoethyl) cytosine and human serum albumin.

Authors:  Feng-Ling Cui; Guang-Quan Hui; Rui-Na Huo; Gui-Rong Qu
Journal:  Mol Biol Rep       Date:  2012-07-19       Impact factor: 2.316

3.  Binding of triclosan to human serum albumin: insight into the molecular toxicity of emerging contaminant.

Authors:  Jiabin Chen; Xuefei Zhou; Yalei Zhang; Yanqin Zi; Yajie Qian; Haiping Gao; Shuangshuang Lin
Journal:  Environ Sci Pollut Res Int       Date:  2012-07-21       Impact factor: 4.223

4.  Binding of quercetin to lysozyme as probed by spectroscopic analysis and molecular simulation.

Authors:  Gongke Wang; Lixia Wang; Wen Tang; Xiaoxiao Hao; Yunlai Wang; Yan Lu
Journal:  J Fluoresc       Date:  2011-04-01       Impact factor: 2.217

5.  Circular dichroism simulation shows a site-II-to-site-I displacement of human serum albumin-bound diclofenac by ibuprofen.

Authors:  K Yamasaki; M H Rahman; Y Tsutsumi; T Maruyama; S Ahmed; U Kragh-Hansen; M Otagiri
Journal:  AAPS PharmSciTech       Date:  2000-05-14       Impact factor: 3.246

6.  Transport of a cancer chemopreventive polyphenol, resveratrol: interaction with serum albumin and hemoglobin.

Authors:  Zhong Lu; Yuying Zhang; Hui Liu; Jianglan Yuan; Zhongliang Zheng; Guolin Zou
Journal:  J Fluoresc       Date:  2007-06-28       Impact factor: 2.217

7.  Interaction of benzothiadiazides with human serum albumin studied by dialysis and spectroscopic methods.

Authors:  N Takamura; M H Rahman; K Yamasaki; M Tsuruoka; M Otagiri
Journal:  Pharm Res       Date:  1994-10       Impact factor: 4.200

8.  Multiple Spectroscopic, Docking and Cytotoxic Study of a Synthesized 2,2' Bipyridin Phenyl Isopentylglycin Pt(II) Nitrate Complex: Human Serum Albumin and Breast Cancer Cell Line of MDA-MB231 as Targets.

Authors:  Sara Nourizadeh; Adeleh Divsalar; Mina Fekri; Behafarid Ghalandari; Mahbubeh Eslami-Moghadam; Ali Akbar Saboury; Saba Abbasi
Journal:  J Fluoresc       Date:  2018-02-23       Impact factor: 2.217

9.  The interaction of folate-modified Bletilla striata polysaccharide-based micelle with bovine serum albumin.

Authors:  Xinying Wang; Guangyuan Zhang; Di Yu; Ning Wang; Qingxiang Guan
Journal:  Glycoconj J       Date:  2021-09-29       Impact factor: 2.916

10.  Characterization of the interaction between eupatorin and bovine serum albumin by spectroscopic and molecular modeling methods.

Authors:  Hongliang Xu; Nannan Yao; Haoran Xu; Tianshi Wang; Guiying Li; Zhengqiang Li
Journal:  Int J Mol Sci       Date:  2013-07-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.